Genetic engineered primary human natural killer cells targeting TIGIT via CRISPR/Cas9 enhanced anti-tumor activity against GBM spheroids and 2D culture.
Ontology highlight
ABSTRACT: Genetic engineered primary human natural killer cells targeting TIGIT via CRISPR/Cas9 enhanced anti-tumor activity against GBM spheroids and 2D culture.
PROVIDER: PRJNA878498 | ENA |
REPOSITORIES: ENA
ACCESS DATA